Consequently, therapeutic strategies for AD are centered on reducing Aβ plaque accumulation, preventing the abnormal phosphorylation of tau protein, mitigating neuroinflammation, and enhancing neuronal function. The gene discussed is MAPT; the disease is Alzheimer disease.